Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
AMAG Pharmaceuticals, Inc. $300 Million Convertible Senior Notes Offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by AMAG Pharmaceuticals, Inc. of $300…
Eli Lilly $2.25 Billion Notes Offering
Davis Polk advised the joint book-running managers in connection with a $2.25 billion registered offering by Eli Lilly…
Flexion Therapeutics $201.25 Million Convertible Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in a Rule 144A offering by Flexion Therapeutics, Inc. of …
Agios Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the…
Galapagos NV €363.9 Million Follow-On Offering of American Depositary Shares
Davis Polk advised the sole book-running manager in connection with Galapagos NV’s offering of 4,312,500 ordinary shares in…
Abbott and Alere Amend Merger Agreement
Davis Polk is advising J.P. Morgan as financial adviser to Alere Inc. in connection with the amendment of the existing terms…
Evolent Health Common Stock Secondary Offering
Davis Polk advised the underwriters in connection with a secondary offering of 7,500,000 shares of Class A common stock of…
Abbott Laboratories $2.9 Billion Exchange Offers and Consent Solicitations
Davis Polk advised the joint lead dealer managers in connection with the registered offers by Abbott Laboratories to…
Davis Polk Advises Penumbra, Inc. on Its Follow-On Offering
Davis Polk advised Penumbra, Inc. on its SEC-registered follow-on public offering of 1,495,000 shares of common stock for an…
Editas Medicine, Inc. $90 Million Follow-On Offering
Davis Polk advised the active joint book-running managers and representatives of the underwriters in connection with the $90…